4//SEC Filing
HALAS GUS D 4
Accession 0001628280-23-010322
CIK 0001448431other
Filed
Apr 2, 8:00 PM ET
Accepted
Apr 3, 12:22 PM ET
Size
7.1 KB
Accession
0001628280-23-010322
Insider Transaction Report
Form 4
OptimizeRx CorpOPRX
HALAS GUS D
Director
Transactions
- Exercise/Conversion
Common Stock
2023-03-30+657→ 66,228 total - Exercise/Conversion
Restricted Stock Units
2023-03-30−657→ 657 total→ Common Stock (657 underlying)
Footnotes (2)
- [F1]Restricted stock units convert into common stock on a one-for-one basis.
- [F2]On March 30, 2022 the reporting person was granted 657 restricted stock units which vested in full on March 30, 2023.
Documents
Issuer
OptimizeRx Corp
CIK 0001448431
Entity typeother
Related Parties
1- filerCIK 0001230322
Filing Metadata
- Form type
- 4
- Filed
- Apr 2, 8:00 PM ET
- Accepted
- Apr 3, 12:22 PM ET
- Size
- 7.1 KB